Vita Coco: Growth Outlook Remains Healthy

Raised guidance improves the outlook, but expectations are higher too

Vita Coco's latest quarter was strong by almost any standard. The company reported Q2 net sales of $216.15 million, up 28% year over year, and raised its full-year view to $790 million-$805 million of 2026 net sales and $154 million-$161 million of adjusted EBITDA. That is exactly what growth investors want to see, but it also raises the bar for the next few quarters.

Investors were already leaning positive. The shares had outperformed the industry in the past six months as confidence in the brand and operating trends improved. So the market did not need this quarter to prove that demand exists. It needed proof that the business can keep clearing a higher standard.

Household penetration and usage are still improving

The most important signal is that growth is still coming from real consumer engagement, not just more shipments. Management said about two-thirds of U.S. branded growth is coming from household penetration, with the rest from higher household velocity. In other words, more households are trying the product and existing buyers are using it more often.

That fits with Vita Coco's broader message that coconut water is gaining traction across hydration, sports, and recovery occasions. When both penetration and frequency are moving the right way, the revenue story usually has more substance.

Volume supports the sales upgrade

The quarter's breakdown also supports the upgrade. Coconut water net sales surged 21% in Q2, while case equivalent volume in the category grew 15%. That volume gain matters because it points to actual retail movement rather than growth driven only by price or mix.

The trend also built on a strong start to the year. In Q1, net sales were $180 million, up 37%, Vita Coco Coconut Water net sales grew 42%, and adjusted EBITDA rose to $39 million. The momentum was not invented in Q2; it carried forward from an already healthy first quarter.

Brand and category momentum are both holding up

Vita Coco is not the only segment growing. Private label volumes also jumped 78% in Q2, which suggests the broader coconut water category remains lively. At the same time, Vita Coco is still the clearest brand proxy for investors because its core line remains the biggest revenue engine and is expected to grow in the high-teens-to-20% range for 2026.

International markets are adding another layer. International segment net sales increased 63% in Q2, and management highlighted Europe as a meaningful expansion opportunity. That diversification matters because it gives the company more than one source of growth if U.S. growth normalizes over time.

What could pressure the stock from here

The product can keep selling well and the stock can still struggle if expectations run ahead of execution. After the upgrade to $790 million-$805 million of net sales and $154 million-$161 million of adjusted EBITDA, the question is no longer whether demand is healthy. It is whether Vita Coco can meet a much higher bar over the second half of the year.

Margin tailwinds may not last

One of the biggest near-term watch items is margin quality. Vita Coco reported gross margin of 49% in Q2, up from 36% a year earlier. That improvement was helped by tariff refunds, better pricing, and lower freight costs. If those benefits fade while guidance stays elevated, the stock has less room for a soft patch.

That is why the next few quarters matter so much. Even if Vita Coco delivers higher household penetration and stronger usage, weaker margin tailwinds could make the recent upgrade look aggressive.

Copra adds upside, but also execution risk

The Copra acquisition adds another variable. It gives Vita Coco exposure to Thailand sourcing and the chilled super-premium Thai Nam Hom coconut water segment, and management expects it to become accretive to adjusted EBITDA margins after full integration. But integration is never automatic, and more geographic exposure adds operating complexity.

The setup in plain terms

The healthy part of the story is still there: penetration, frequency, volume, and category momentum are mostly moving the right way. The tougher part is the stock setup. After a sharp run and a raised outlook, investors are no longer buying proof of demand. They are buying the likelihood that Vita Coco can continue to outperform a newly elevated bar.